Lung Cancer Treatment Drugs Market Insights Video

According to Cognitive Market Research, the global Lung Cancer Treatment Drugs market size was USD 40258.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 10.50% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 16103.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 12077.55 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 9259.46 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.5% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 2012.93 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 805.17 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.
• The Immunotherapy category is the fastest growing segment of the Lung Cancer Treatment Drugs industry